MedPath

Clinical impact of carbon dioxide insufflation during ERCP; A phase 3, open-label, randomized controled trial.

Phase 3
Conditions
pancreato-biliary disease
Registration Number
JPRN-UMIN000005755
Lead Sponsor
department of gastroenterology, Nagoya daini red cross hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

inability to provide informed consent chronic obstructive pulmonary disease severe abdominal pain before ERCP pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual analogue scale (VAS)
Secondary Outcome Measures
NameTimeMethod
change of waist size duration of sedative effect safety
© Copyright 2025. All Rights Reserved by MedPath